Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Cancer Institute, KK Women’s and Children’s Hospital - Department of Reproductive Medicine, KK Women’s and Children’s Hospital - Department of Reproductive Medicine, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Government of the United States of America - National Cancer Institute and Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID)

Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), Centre de Recherche en Cancérologie de Lyon, Université Toulouse III - Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, University of Toronto - Department of Immunology, Université Toulouse III - Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université Toulouse III - Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Centre de Recherche en Cancérologie de Lyon, University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT) and University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT)